Efficacy & Safety of ANX005 in Subjects With Guillain-Barré Syndrome

See also
Status	Clinical Trial	Phase
Terminated	`NCT04053452` - Peripheral Nerve Ultrasound for Diagnosis and Prognosis of Guillain-Barre Syndrome	N/A
Recruiting	`NCT02582853` - sCD163 as a Potential Biomarker in Guillain- Barré Syndrome	N/A
Completed	`NCT00056810` - Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridine	Phase 2
Completed	`NCT05104762` - IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients	Phase 2/Phase 3
Recruiting	`NCT05630313` - Gene Sequencing as a Strategy for Identifying Genetic Factors Associated With Serious Adverse Events After Covid-19 Vaccines in Use in Brazil
Recruiting	`NCT03801135` - Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation	N/A
Active, not recruiting	`NCT01655394` - Change of Nerve Conduction Properties in IVIg Dependent Neuropathies	N/A
Completed	`NCT04927598` - Predictors and Prognostic Factors of Gullian Barrie Syndrome Outcome
Completed	`NCT06334796` - Artificial Intelligence-powered Virtual Assistant for Emergency Triage in Neurology	Early Phase 1
Not yet recruiting	`NCT04092140` - Neuromuscular Ultrasound in Correlation to Neurophysiological Findings
Not yet recruiting	`NCT04550611` - Mini-pool Intravenous Immunoglobulin (MP-IVIG) in Guillain-Barré Syndrome	N/A
Withdrawn	`NCT03268304` - Feasibility of Two New Software Modules for the Rehabilitation of Patients With Neuromuscular Upper Limb Impairments
Not yet recruiting	`NCT05701189` - Evaluating Efgartigimod in Patients With Guillain-Barré Syndrome	Phase 2
Withdrawn	`NCT02459808` - Gastrointestinal Transit Time in Patients With Guillain-Barré Syndrome	N/A
Completed	`NCT04752566` - A Study to Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré Syndrome	Phase 3
Completed	`NCT05292690` - An Assistive Powered Wheelchair: Stage 2 Trial
Not yet recruiting	`NCT06300359` - Prognostic Indicators of Gullian-Barre Syndrome
Completed	`NCT00575653` - Safety Study of GBS Following Menactra Meningococcal Vaccination	N/A
Completed	`NCT05491096` - Effects of Proprioceptive Neuromuscular Training on Sensory and Motor Function in Guillain Barre Syndrome	N/A
Not yet recruiting	`NCT05114941` - Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome	N/A

NCT number	NCT04701164
Study type	Interventional
Source	Annexon, Inc.
Contact	Study Coordinator
Phone	650-822-5500
Email	clinicaltrials@annexonbio.com
Status	Recruiting
Phase	Phase 3
Start date	December 17, 2020
Completion date	April 30, 2024

Efficacy and Safety of ANX005 in Subjects With Guillain-Barré Syndrome

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms